187 related articles for article (PubMed ID: 12697670)
1. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).
Schneyer A; Schoen A; Quigg A; Sidis Y
Endocrinology; 2003 May; 144(5):1671-4. PubMed ID: 12697670
[TBL] [Abstract][Full Text] [Related]
2. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
[TBL] [Abstract][Full Text] [Related]
3. Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG).
Arai KY; Tsuchida K; Li C; Watanabe G; Sugino H; Taya K; Nishiyama T
Protein Expr Purif; 2006 Sep; 49(1):78-82. PubMed ID: 16737827
[TBL] [Abstract][Full Text] [Related]
4. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function.
Bartholin L; Maguer-Satta V; Hayette S; Martel S; Gadoux M; Corbo L; Magaud JP; Rimokh R
Oncogene; 2002 Mar; 21(14):2227-35. PubMed ID: 11948405
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
6. Heparin and activin-binding determinants in follistatin and FSTL3.
Sidis Y; Schneyer AL; Keutmann HT
Endocrinology; 2005 Jan; 146(1):130-6. PubMed ID: 15471966
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of the activin/follistatin system in hepatocarcinogenesis.
Grusch M; Drucker C; Peter-Vörösmarty B; Erlach N; Lackner A; Losert A; Macheiner D; Schneider WJ; Hermann M; Groome NP; Parzefall W; Berger W; Grasl-Kraupp B; Schulte-Hermann R
J Hepatol; 2006 Nov; 45(5):673-80. PubMed ID: 16935389
[TBL] [Abstract][Full Text] [Related]
8. Novel factors in regulation of activin signaling.
Tsuchida K; Nakatani M; Matsuzaki T; Yamakawa N; Liu Z; Bao Y; Arai KY; Murakami T; Takehara Y; Kurisaki A; Sugino H
Mol Cell Endocrinol; 2004 Oct; 225(1-2):1-8. PubMed ID: 15451561
[TBL] [Abstract][Full Text] [Related]
9. Developmental profiles of activin betaA, betaB, and follistatin expression in the zebrafish ovary: evidence for their differential roles during sexual maturation and ovulatory cycle.
Wang Y; Ge W
Biol Reprod; 2004 Dec; 71(6):2056-64. PubMed ID: 15329331
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the inhibition of activin signalling by follistatin.
Harrington AE; Morris-Triggs SA; Ruotolo BT; Robinson CV; Ohnuma S; Hyvönen M
EMBO J; 2006 Mar; 25(5):1035-45. PubMed ID: 16482217
[TBL] [Abstract][Full Text] [Related]
11. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
[TBL] [Abstract][Full Text] [Related]
12. Follistatin-related protein (FSRP): a new member of the follistatin gene family.
Schneyer A; Tortoriello D; Sidis Y; Keutmann H; Matsuzaki T; Holmes W
Mol Cell Endocrinol; 2001 Jun; 180(1-2):33-8. PubMed ID: 11451569
[TBL] [Abstract][Full Text] [Related]
13. Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding.
Fischer WH; Park M; Donaldson C; Wiater E; Vaughan J; Bilezikjian LM; Vale W
J Endocrinol; 2003 Jan; 176(1):61-8. PubMed ID: 12525250
[TBL] [Abstract][Full Text] [Related]
14. Activin-A binds follistatin and type II receptors through overlapping binding sites: generation of mutants with isolated binding activities.
Harrison CA; Chan KL; Robertson DM
Endocrinology; 2006 Jun; 147(6):2744-53. PubMed ID: 16527838
[TBL] [Abstract][Full Text] [Related]
15. Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid.
Glister C; Groome NP; Knight PG
J Endocrinol; 2006 Feb; 188(2):215-25. PubMed ID: 16461548
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin.
Aoki F; Kurabayashi M; Hasegawa Y; Kojima I
Am J Respir Crit Care Med; 2005 Sep; 172(6):713-20. PubMed ID: 15976370
[TBL] [Abstract][Full Text] [Related]
18. The role of follistatin domains in follistatin biological action.
Keutmann HT; Schneyer AL; Sidis Y
Mol Endocrinol; 2004 Jan; 18(1):228-40. PubMed ID: 14563935
[TBL] [Abstract][Full Text] [Related]
19. Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide.
Florio P; Ciarmela P; Toti P; Maguer-Satta V; Rimokh R; Buonocore G; Rossi M; Gioffrè W; Petraglia F
Mol Cell Endocrinol; 2004 Apr; 218(1-2):129-35. PubMed ID: 15130517
[TBL] [Abstract][Full Text] [Related]
20. Expression of FLRG, a novel activin A ligand, is regulated by TGF-beta and during hematopoiesis [corrected].
Maguer-Satta V; Bartholin L; Jeanpierre S; Gadoux M; Bertrand S; Martel S; Magaud JP; Rimokh R
Exp Hematol; 2001 Mar; 29(3):301-8. PubMed ID: 11274757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
